vials of tirzepatide + Vitamin B12 10 mg/ml (2ml vial) hormone GLP Compounded GLP-1 - Semaglutide &

More participants in the semaglutide group than in the placebo group achieved weight reductions of 5% or more (86% of participants vs 32%), 10% or more (69% vs 12%) and 15% or more (51% vs 5%) at week 68

Regulatory approvals currently include indications for Type 2 diabetes mellitus (T2DM), Chronic kidney disease (CKD), and heart failure

Women's bodies are more sensitive to this response, likely due to evolutionary pressures related to reproduction and energy preservation

Membership, shipping, and all supplies are included for compounded meds

Based on the results of your diagnostic tests, we create a personalized wellness plan tailored to your specific needs

may go up to 14 mg daily if needed